DK1007522T3 - 2-4-[4-(4,5-dichlor-2-methylimidazol-1-yl)butyl]-1-piperazin-1-yl-5-fluorpyrimidin, fremstilling deraf og terapeutisk anvendelse deraf - Google Patents

2-4-[4-(4,5-dichlor-2-methylimidazol-1-yl)butyl]-1-piperazin-1-yl-5-fluorpyrimidin, fremstilling deraf og terapeutisk anvendelse deraf

Info

Publication number
DK1007522T3
DK1007522T3 DK98967138T DK98967138T DK1007522T3 DK 1007522 T3 DK1007522 T3 DK 1007522T3 DK 98967138 T DK98967138 T DK 98967138T DK 98967138 T DK98967138 T DK 98967138T DK 1007522 T3 DK1007522 T3 DK 1007522T3
Authority
DK
Denmark
Prior art keywords
methylimidazol
fluoropyrimidine
dichloro
butyl
piperazin
Prior art date
Application number
DK98967138T
Other languages
Danish (da)
English (en)
Inventor
Ramon Merce-Vidal
Jordi Frigola-Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Application granted granted Critical
Publication of DK1007522T3 publication Critical patent/DK1007522T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98967138T 1997-06-02 1998-05-28 2-4-[4-(4,5-dichlor-2-methylimidazol-1-yl)butyl]-1-piperazin-1-yl-5-fluorpyrimidin, fremstilling deraf og terapeutisk anvendelse deraf DK1007522T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706738A FR2763950B1 (fr) 1997-06-02 1997-06-02 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique
PCT/EP1998/003190 WO1998055476A1 (fr) 1997-06-02 1998-05-28 2-{4-[4-(4,5-dichloro-2- methylimidazol-1-yl)butyl] -1-piperazinyl}-5-fluoropyrimidine, sa preparation et son utilisation therapeutique

Publications (1)

Publication Number Publication Date
DK1007522T3 true DK1007522T3 (da) 2003-03-17

Family

ID=9507480

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98967138T DK1007522T3 (da) 1997-06-02 1998-05-28 2-4-[4-(4,5-dichlor-2-methylimidazol-1-yl)butyl]-1-piperazin-1-yl-5-fluorpyrimidin, fremstilling deraf og terapeutisk anvendelse deraf

Country Status (22)

Country Link
US (2) US6303608B1 (de)
EP (1) EP1007522B1 (de)
JP (1) JP4344890B2 (de)
KR (1) KR100556559B1 (de)
CN (1) CN1094491C (de)
AT (1) ATE228126T1 (de)
AU (1) AU732722B2 (de)
BR (1) BR9810240A (de)
CA (1) CA2292746A1 (de)
DE (1) DE69809564T2 (de)
DK (1) DK1007522T3 (de)
ES (1) ES2149691B1 (de)
FR (1) FR2763950B1 (de)
HU (1) HUP0002905A3 (de)
IL (1) IL133216A0 (de)
NO (1) NO318757B1 (de)
NZ (1) NZ501566A (de)
PL (1) PL190777B1 (de)
PT (1) PT1007522E (de)
RU (1) RU2191184C2 (de)
TR (1) TR199903001T2 (de)
WO (1) WO1998055476A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101152658B1 (ko) * 2009-04-30 2012-06-18 한국과학기술연구원 세로토닌 5-ｈｔ6 길항 활성 효과를 갖는 피페라진 화합물 함유 조성물
RU2660583C1 (ru) * 2017-08-15 2018-07-06 Общество С Ограниченной Ответственностью "Валента - Интеллект" Применение буспирона для лечения функционального головокружения

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2672052B1 (fr) 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2712808B1 (fr) * 1993-11-25 1996-02-16 Esteve Labor Dr Utilisation des dérivés de 1-{4-[4-aryl(ou hétéroaryl)-1-pipérazinyl]-butyl}-1-H-azole pour la préparation de médicaments destinés au traitement des troubles de la sécrétion gastrique .
FR2742052B1 (fr) * 1995-12-12 1998-04-10 Esteve Labor Dr Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports

Also Published As

Publication number Publication date
KR100556559B1 (ko) 2006-03-06
IL133216A0 (en) 2001-03-19
CN1094491C (zh) 2002-11-20
US6303608B1 (en) 2001-10-16
PL337113A1 (en) 2000-07-31
BR9810240A (pt) 2000-09-05
ES2149691B1 (es) 2001-05-16
RU2191184C2 (ru) 2002-10-20
HUP0002905A3 (en) 2002-01-28
JP4344890B2 (ja) 2009-10-14
EP1007522B1 (de) 2002-11-20
NO318757B1 (no) 2005-05-02
DE69809564T2 (de) 2003-07-10
DE69809564D1 (de) 2003-01-02
HUP0002905A2 (hu) 2001-06-28
KR20010013274A (ko) 2001-02-26
TR199903001T2 (xx) 2000-07-21
FR2763950A1 (fr) 1998-12-04
NO995894D0 (no) 1999-12-01
CA2292746A1 (fr) 1998-12-10
WO1998055476A1 (fr) 1998-12-10
US6346620B1 (en) 2002-02-12
EP1007522A1 (de) 2000-06-14
FR2763950B1 (fr) 2002-09-20
AU7917098A (en) 1998-12-21
CN1261888A (zh) 2000-08-02
NZ501566A (en) 2001-06-29
ATE228126T1 (de) 2002-12-15
PL190777B1 (pl) 2006-01-31
NO995894L (no) 2000-02-01
PT1007522E (pt) 2003-04-30
AU732722B2 (en) 2001-04-26
JP2002501539A (ja) 2002-01-15
ES2149691A1 (es) 2000-11-01

Similar Documents

Publication Publication Date Title
NO324230B1 (no) Anvendelse av 1- [4-(5-cyanindol-3yl)butyl ]-4-(2-karbamoylbenzofuran-5-yl)-piperazin og dets fysiologisk akseptable salter til fremstilling av medikamenter for behandling av bipolare forstyrrelser og mani
ATE363282T1 (de) Zusammensetzung zur unterdrückung von magensäure
DE60134453D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von ZNS und anderen Krankheiten
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
ATE348829T1 (de) Pharmazeutische zusammensetzungen zur behandlung von störungen des zns oder anderen erkrankungen
JO2371B1 (en) 4-phenyl-pyridine derivatives
EA200400881A1 (ru) Азаарилпиперазины
DE69814394D1 (de) Verwendung von levobupivacain
ATE542534T1 (de) Methode zur schmerzbekämpfung
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
NO20015931L (no) Farmasöytiske formuleringer og fremgangsmåter som omfatter intranasal morfin
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
NO20033910L (no) Fremgangsmåte og doseringsform for behandling av tumorer ved administreringav tegafur, uracil, folinsyre, paclitaxel og karboplatin
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
EP1262197A3 (de) Kombinationstherapie zur Behandlung von Schlafstörungen, Schlaflosigkeit inbegriffen
NO20006547L (no) Salter av paroxetine
PT1007522E (pt) 2-4-¬4-(4,5-dicloro-2-metilimidazol-1-il)butil|-1-piperazin-1-il-5-fluoropirimidina sua preparacao e sua utilizacao terapeutica
BR0009080A (pt) Método de tratamento da apnéia do sono
NZ334571A (en) Pharmaceutical composition comprising 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy-acetic acid for treating diseases induced by respiratory syncytial virus
NO20030155L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
ATE404192T1 (de) Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
NO20024291D0 (no) Ny anvendelse av (R)-(-)-2[5-(4-fluorfenyl)-3- pyridylmetylaminometyl]kroman og dets fysiologisk akseptablesalter
DK1105132T3 (da) Anvendelse af R(+)-G(A)-(2,3-dimethoxyphenyl)-1-[2-(4-fluorphenyl)ethyl]-4-piperidinemethanol til behandling af obstruktiv søvnapnø
MX9706133A (es) Uso de los derivados de 1-{4-[4-aril(o heteroaril)-1-piperazinil]-butil}-1h-azol para la preparacion de un medicamento destinado al tratamiento de lostrastornos obsesivo-compulsivos, de la apnea del sueño, de las disfunciones sexuales, de la emesis
SE9800359D0 (sv) Pharmaceutical preparation and method for treatment, prevention and diagnosis of gastrooesophageal reflux disease